Tech Company Financing Transactions
Mitokyne Funding Round
Mitokyne, operating out of Boston, secured $15 million from MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
MPM Capital (Ansbert Gadicke)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Clarendon St. 54th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Email Address
Not Recorded
Overview
Mitokyne is a biotech company focused on mitochondria-related drug discovery and development. The company is utilizing its innovative screening platform to identify and develop novel drugs that improve mitochondria function and provide treatments for genetic, metabolic and neurodegenerative disorders as well as diseases and conditions of aging.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kazumi Shiosaki
Browse more venture capital transactions:
Prev: 12/31/2014: Galleon Pharmaceuticals venture capital transaction
Next: 12/31/2014: Conviva venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs